Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771914 · ClinicalTrials.gov registry record · Phase 1
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00771914 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 27 participants.
The verdict
NCT00771914, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if omega-3 fatty acids enhance the antiplatelet effects of aspirin.
Interventions
- OTHER Placebo
- DRUG Aspirin
- DRUG Lovaza
- DRUG Both Aspirin and Lovaza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771914
The ClinicalTrials.gov registry entry for NCT00771914 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00771914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771914 about?
NCT00771914 is a clinical study titled "The Effects of Omega-3 Fatty Acids on Aspirin Resistance". The purpose of this study is to determine if omega-3 fatty acids enhance the antiplatelet effects of aspirin.
What is the current status of trial NCT00771914?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2008-11. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00771914?
The interventions under investigation include: Placebo (OTHER), Aspirin (DRUG), Lovaza (DRUG), Both Aspirin and Lovaza (DRUG).
Who is sponsoring clinical trial NCT00771914?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.